Strategic Partnerships Maypro has active and high-profile distribution partnerships with large players such as Asahi Group Foods and Tradichem Group, plus a recent collaboration with ITOCHU. This presents cross-sell opportunities to align ingredients like LNDP and Clonapure with distributors’ networks in multiple regions, accelerating market entry for new nutraceutical ingredients.

North America Expansion The launch of PeptiDrive-LNDP in North America alongside a global distribution deal signals a rapid growth trajectory and market receptivity for LNDP-based products. Sales teams should target North American manufacturers and brands seeking scientifically backed, novel peptide ingredients to differentiate their portfolios.

Creatine Innovation Clonapure’s rapid-absorption creatine complex addresses multiple performance and metabolic health segments. There is potential to upsell to sports nutrition brands, women’s health, and functional fitness lines seeking enhanced bioavailability and clinically validated outcomes.

Global Market Access Partnerships with international distributors and suppliers, backed by a network including ITOCHU, position Maypro to offer a broad geographic footprint. Sales opportunities exist in regions where these partners have strong penetration, enabling faster placement of new ingredients and finished products.

Evidence-Driven Selling Maypro emphasizes science-backed ingredients and a 360-degree trend identification approach. Leverage this by targeting R&D-led brands and formulators that prioritize clinical data, literature support, and market validation when evaluating ingredient suppliers.